MONTREAL, QUEBEC--(Marketwire - November 27, 2007) - MethylGene Inc. (TSX: MYG) today announced that Donald F. Corcoran, President and Chief Executive Officer of MethylGene, will present at the BMO Capital Markets Focus on Healthcare Conference in New York City on Tuesday, December 4, 2007 at 11:30a.m. EST. Mr. Corcoran will provide a general update on the Company including its histone deacetylase and kinase programs.
